150 related articles for article (PubMed ID: 38611004)
21. Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
Wishart GC; Greenberg DC; Britton PD; Chou P; Brown CH; Purushotham AD; Duffy SW
Br J Cancer; 2008 Jun; 98(11):1741-4. PubMed ID: 18506175
[TBL] [Abstract][Full Text] [Related]
22. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
Kou K; Cameron J; Youl P; Pyke C; Chambers S; Dunn J; Aitken JF; Baade PD
Breast Cancer; 2023 May; 30(3):466-477. PubMed ID: 36809492
[TBL] [Abstract][Full Text] [Related]
23. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
[TBL] [Abstract][Full Text] [Related]
24. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
25. Effect of mammography screening on the long-term survival of breast cancer patients: results from the National Cancer Screening Program in Korea.
Luu XQ; Lee K; Jun JK; Suh M; Jung KW; Choi KS
Epidemiol Health; 2022; 44():e2022094. PubMed ID: 36317402
[TBL] [Abstract][Full Text] [Related]
26. Are international differences in breast cancer survival between Australia and the UK present amongst both screen-detected women and non-screen-detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006.
Woods LM; Rachet B; O'Connell DL; Lawrence G; Coleman MP
Int J Cancer; 2016 May; 138(10):2404-14. PubMed ID: 26756306
[TBL] [Abstract][Full Text] [Related]
27. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women.
Wang WV; Tan SM; Chow WL
Asian Pac J Cancer Prev; 2011; 12(10):2735-40. PubMed ID: 22320984
[TBL] [Abstract][Full Text] [Related]
28. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series.
Crispo A; Barba M; D'Aiuto G; De Laurentiis M; Grimaldi M; Rinaldo M; Caolo G; D'Aiuto M; Capasso I; Esposito E; Amore A; Di Bonito M; Botti G; Montella M
BMC Cancer; 2013 Jan; 13():15. PubMed ID: 23305429
[TBL] [Abstract][Full Text] [Related]
29. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
Gunsoy NB; Garcia-Closas M; Moss SM
Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
[TBL] [Abstract][Full Text] [Related]
30. Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study).
Hernández-García M; Molina-Barceló A; Vanaclocha-Espi M; Zurriaga Ó; Pérez-Gómez B; Aragonés N; Amiano P; Altzibar JM; Castaño-Vinyals G; Sala M; Ederra M; Martín V; Gómez-Acebo I; Vidal C; Tardón A; Marcos-Gragera R; Pollán M; Kogevinas M; Salas D
Cancer Causes Control; 2022 Jan; 33(1):125-136. PubMed ID: 34817770
[TBL] [Abstract][Full Text] [Related]
31. Mammography use and mode of detection among breast cancer patients in Estonia.
Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
[TBL] [Abstract][Full Text] [Related]
32. Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands.
de Munck L; Siesling S; Fracheboud J; den Heeten GJ; Broeders MJM; de Bock GH
Br J Cancer; 2020 Sep; 123(7):1191-1197. PubMed ID: 32641863
[TBL] [Abstract][Full Text] [Related]
33. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.
Cardoso R; Guo F; Heisser T; De Schutter H; Van Damme N; Nilbert MC; Christensen J; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Walsh PM; Senore C; Rosso S; Lemmens VEPP; Elferink MAG; Tomšič S; Žagar T; Marques ALM; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Sánchez-Gil A; Chirlaque MD; Hoffmeister M; Brenner H
Lancet Reg Health Eur; 2022 Oct; 21():100458. PubMed ID: 35832063
[TBL] [Abstract][Full Text] [Related]
34. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study.
Pollán M; Ascunce N; Ederra M; Murillo A; Erdozáin N; Alés-Martínez J; Pastor-Barriuso R
Breast Cancer Res; 2013 Jan; 15(1):R9. PubMed ID: 23360535
[TBL] [Abstract][Full Text] [Related]
35. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
[TBL] [Abstract][Full Text] [Related]
36. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
[TBL] [Abstract][Full Text] [Related]
37. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
38. Screening and cervical cancer cure: population based cohort study.
Andrae B; Andersson TM; Lambert PC; Kemetli L; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S; Sparén P
BMJ; 2012 Mar; 344():e900. PubMed ID: 22381677
[TBL] [Abstract][Full Text] [Related]
39. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.
Kaplan HG; Malmgren JA; Atwood MK; Calip GS
Cancer; 2015 Aug; 121(15):2553-61. PubMed ID: 25872471
[TBL] [Abstract][Full Text] [Related]
40. [Early effects of attendance to the Friuli Venezia Giulia (Northern Italy) mammography screening programme on the incidence of advanced-stage breast cancer: a cohort study].
Giudici F; Bortul M; Clagnan E; Del Zotto S; Franzo A; Giordano L; Gobbato M; Puliti D; Serraino D; Zucchetto A; Zanier L; Zanconati F; Bucchi L
Epidemiol Prev; 2020; 44(2-3):145-153. PubMed ID: 32631014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
